Humana, UnitedHealthcare Hit Hard as Star Ratings Decline for Third Year
-
Oct 17, 2024
CMS on Oct. 10 released the 2025 Medicare Advantage and Part D Star Ratings, revealing a continued decline in the number of plans achieving high ratings. Only 40% of Medicare Advantage Prescription Drug (MA-PD) contracts earned 4 stars or higher for the 2025 plan year, though 62% of all MA-PD members are enrolled in these highly rated contracts, which will qualify for bonus payments in 2026. This marks the third consecutive year of declining ratings, reflecting the continued return to normal after pandemic-era flexibilities and the impact of the second year of the Tukey outlier deletion methodology, which in some cases “caused an upward shift in cut points,” CMS explained. Just seven contracts received a 5-star rating, a steep decline from 38 in 2024. An additional seven contracts — five from Centene Corp., one from CVS Health Corp.’s Aetna and one from Zing Health — received the "low-performing" indicator. Read more
© 2024 MMIT
The Latest
Meet Our Reporters
Meet Our Reporters
GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND
Sign up for publications to get unmatched business intelligence delivered to your inbox.